Enveric Biosciences to present at H.C. Wainwright Global Investment Conference
ENVB•Conference presentation details
Enveric Biosciences will present at the H.C. Wainwright 28th Annual Global Investment Conference in New York on September 14-16, 2026.
A prerecorded virtual presentation is scheduled for 7:00 a.m. ET on September 11, 2026.
CEO Joseph Tucker will outline progress on EB-003, including IND-enabling work ahead of a planned IND submission.
